Skip to main content
. Author manuscript; available in PMC: 2013 Dec 1.
Published in final edited form as: Hepatology. 2012 Dec;56(6):2094–2105. doi: 10.1002/hep.25951

Table 1. Demographics of studied subjects.

Liver histology scored by Metavir system or modified Ishak converted to Metavir scores. HAI: stage+grade. Progression rate for rapid progressors >0.1 Metavir/yr. ALT: alanine-aminotransferase.

Rapid progressors Slow progressors
Characteristic (n = 6) (n = 13) P
Age: median (range), yr 57 (38 – 59) 57 (38 – 66) 0.67
Race 5 C; 1 Asian 10 C; 1 AA; 2 Asian
Male / female sex 5 / 1 9 / 4
HCV RNA, median (range), copies × 103 IU/mL 2,025 (594 – 17,800) 1,210 (31.5 – 14,600) 0.80
HCV genotype (no.) 1 (6) 1 (12), 3 (1)
ALT: median (range) 81 (34 – 101) 59 (34 – 417) 0.83
Liver Inflammation Grade: median (range) 1 (1 – 3) 1 (1 – 2) 0.47
Liver Fibrosis Stage: median (range) 2 (2 – 4) 1 (0 – 2) 0.006
Histological activity index (HAI): median (range) 3 (3 – 5) 2 (1 – 4) 0.009
Fibrosis progression rate: median (range), Metavir/yr 0.2 (0.1 – 0.67) 0.0 (−0.167 – 0.074) 0.0005
Time between 2 biopsies: median (range), yr 4.9 (3.46 – 5.21) 4.26 (3.85 – 6.76) 0.44